Senior insider sale
Chief Financial Officer at PUMA BIOTECHNOLOGY, INC. — senior position signals high conviction
$77.6K
9.39K shares
What this filing means
NOUGUES MAXIMO F plans to sell 9.39K shares of PUMA BIOTECHNOLOGY, INC. valued at approximately $77.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/6/2026ACC: 0001959173-26-005121
Officer· Chief Financial Officer
Since Nov 2018
9.39K
Shares to sell
$77.6K
Approx. market value
9.39K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
7/1/2026
9.39KTotal acquired9.39K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/1/2026 | Restricted Stock Vesting Compensation | 9.39K | — |
| Total | 9.39K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
9.39K
Market value
$77.6K
7/6/2026
Total
Units
9.39K
Value
$77.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/6/2026 | 9.39K | $77.6K | NASDAQ | Planned |
| Total | 9.39K | $77.6K | ||